Danil V. Makarov

6.4k total citations · 3 hit papers
172 papers, 4.5k citations indexed

About

Danil V. Makarov is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Danil V. Makarov has authored 172 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 40 papers in Economics and Econometrics. Recurrent topics in Danil V. Makarov's work include Prostate Cancer Diagnosis and Treatment (59 papers), Prostate Cancer Treatment and Research (52 papers) and Health Systems, Economic Evaluations, Quality of Life (26 papers). Danil V. Makarov is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (59 papers), Prostate Cancer Treatment and Research (52 papers) and Health Systems, Economic Evaluations, Quality of Life (26 papers). Danil V. Makarov collaborates with scholars based in United States, United Kingdom and Germany. Danil V. Makarov's co-authors include Alan W. Partin, Jonathan I. Epstein, Cary P. Gross, Stacy Loeb, James B. Yu, Elizabeth B. Humphreys, Patrick C. Walsh, Bruce J. Trock, Leslie A. Mangold and Robert W. Veltri and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Danil V. Makarov

167 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

2017 583 citations Martin G. Sanda, Jeffrey A. Cadeddu et al. The Journal of Urology profile →
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options

2018 252 citations Martin G. Sanda, Jeffrey A. Cadeddu et al. The Journal of Urology profile →
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US

2023 70 citations Matthew R. Cooperberg, William Meeks et al. JAMA Network Open profile →

Peers

Countries citing papers authored by Danil V. Makarov

Since Specialization

Citations

This map shows the geographic impact of Danil V. Makarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danil V. Makarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danil V. Makarov more than expected).

Fields of papers citing papers by Danil V. Makarov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danil V. Makarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danil V. Makarov. The network helps show where Danil V. Makarov may publish in the future.

Co-authorship network of co-authors of Danil V. Makarov

This figure shows the co-authorship network connecting the top 25 collaborators of Danil V. Makarov. A scholar is included among the top collaborators of Danil V. Makarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danil V. Makarov. Danil V. Makarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Framework for Integrating Telehealth Equitably across the cancer care continuum 2024 ·JNCI Monographs ·Katharine A. Rendle, Andy S.L. Tan, Bonnie Spring, Erin M. Bange, Allison Lipitz‐Snyderman, Michael J. Morris, Danil V. Makarov, (unknown), Sofia F. Garcia, Brian Hitsman, (unknown), Siobhan M. Phillips, Scott E. Sherman, Peter D. Stetson, Anil Vachani, (unknown), Leah L. Zullig, Justin E. Bekelman	6
2	Experiences of oncology researchers in the Veterans Health Administration during the COVID-19 pandemic 2024 ·PLoS ONE ·Daniel Becker, (unknown), (unknown), (unknown), Stacy Loeb, Danil V. Makarov, Scott E. Sherman, Sahnah Lim	1
3	Telehealth Research and Innovation for Veterans with Cancer: the THRIVE Center 2024 ·JNCI Monographs ·Leah L. Zullig, Danil V. Makarov, Daniel Becker, (unknown), (unknown), Michael J. Kelley, (unknown), (unknown), (unknown), Jerry R. Thomas, (unknown), Scott E. Sherman	2
4	Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US breakdown → 2023 ·JAMA Network Open ·Matthew R. Cooperberg, William Meeks, Raymond Fang, Franklin Gaylis, William J. Catàlona, Danil V. Makarov	70
5	Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities 2023 ·JCO Oncology Practice ·Nnenaya A. Mmonu, Yongmei Qin, Samuel R. Kaufman, Mary Oerline, Randy Vince, Danil V. Makarov, Megan E.V. Caram, Christina Chapman, Joseph Ravenell, Brent K. Hollenbeck, Ted A. Skolarus	2
6	Veterans Health Administration National TeleOncology Service 2023 ·JCO Oncology Practice ·Leah L. Zullig, (unknown), (unknown), Scott E. Sherman, Danil V. Makarov, Daniel Becker, Heather A. King, John Pura, Amy S. Jeffreys, Susanne Danus, Vida Almario Passero, Karen M. Goldstein, Michael J. Kelley	10
7	Urologists’ Perceptions and Practices Related to Patient Smoking and Cessation: A National Assessment From the 2021 American Urological Association Census 2023 ·Urology ·Richard S. Matulewicz, William Meeks, (unknown), Raymond Fang, (unknown), Matthew Mossanen, Helena Furberg, (unknown), Michelle Lui, Scott E. Sherman, Danil V. Makarov, Marc A. Bjurlin, Jamie S. Ostroff	2
8	COVID‐19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system 2021 ·Cancer ·(unknown), (unknown), Lena Masri, Abhishek Pandey, Meng Cao, (unknown), Marissa Rybstein, (unknown), (unknown), (unknown), Danil V. Makarov, Scott E. Sherman, (unknown), Alexander C. Jordan, Beatrice M. Razzo, (unknown), Joseph Tsai, Daniel Becker	25
9	Interaction between race and prostate cancer treatment benefit in the Veterans Health Administration 2021 ·Cancer ·(unknown), Dawn Walter, (unknown), (unknown), Chan Wang, Angela Fagerlin, Aisha T. Langford, Herbert Lepor, Daniel Becker, Huilin Li, Stacy Loeb, Joseph Ravenell, John T. Leppert, Danil V. Makarov	14
10	Protocol: A multi-modal, physician-centered intervention to improve guideline-concordant prostate cancer imaging 2021 ·Trials ·Danil V. Makarov, (unknown), (unknown), Dawn Walter, Michele G. Shedlin, R. Scott Braithwaite, Craig Tenner, Heather T. Gold, Steven B. Zeliadt, Scott E. Sherman	1
11	The Association of Veterans’ PSA Screening Rates With Changes in USPSTF Recommendations 2020 ·JNCI Journal of the National Cancer Institute ·Daniel Becker, (unknown), Dawn Walter, Chan Wang, Stacy Loeb, Huilin Li, (unknown), (unknown), Steven B. Zeliadt, Angela Fagerlin, Herbert Lepor, Scott E. Sherman, Joseph Ravenell, Danil V. Makarov	10
12	PD53-10 A PILOT STUDY TO COMPARE A COMMUNITY HEALTH WORKER-LED VS A PHYSICIAN-LED INTERVENTION FOR PROSTATE CANCER SCREENING DECISION-MAKING AMONG BLACK MEN 2020 ·The Journal of Urology ·(unknown), Danil V. Makarov, (unknown), (unknown), Helen Cole, (unknown), Michael Fenstermaker, Heather T. Gold, Stacy Loeb, Joseph Ravenell	1
13	Significant Management Variability of Urethral stricture Disease in United States: Data from the AUA Quality (AQUA) Registry 2020 ·Urology ·Andrew J. Cohen, Nnenaya A. Mmonu, Danil V. Makarov, William Meeks, John Murphy, Raymond Fang, Matthew R. Cooperberg, Benjamin N. Breyer	4
14	Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options breakdown → 2017 ·The Journal of Urology ·Martin G. Sanda, Jeffrey A. Cadeddu, Erin Kirkby, Ronald C. Chen, Tony Crispino, Joann Fontanarosa, Stephen J. Freedland, Kirsten L. Greene, Laurence Klotz, Danil V. Makarov, Joel B. Nelson, George Rodrigues, Howard M. Sandler, Mary Ellen Taplin, Jonathan Treadwell	583
15	Are hospitals “keeping up with the Joneses”?: Assessing the spatial and temporal diffusion of the surgical robot 2014 ·Healthcare ·Huilin Li, Mitchell H. Gail, R. Scott Braithwaite, Heather T. Gold, Dawn Walter, Mengling Liu, Cary P. Gross, Danil V. Makarov	11
16	The Effect of the Diffusion of the Surgical Robot on the Hospital-level Utilization of Partial Nephrectomy 2014 ·Medical Care ·Ganesh Sivarajan, Glen B. Taksler, (unknown), Cary P. Gross, (unknown), Danil V. Makarov	33
17	Determinants of Enrollment in Cancer Clinical Trials: The Relationship Between the Current State of Knowledge, Societal Disease Burden, and Randomized Clinical Trial Enrollment 2013 ·Journal of the National Comprehensive Cancer Network ·Shane Lloyd, Daniela L. Buscariollo, Cary P. Gross, Danil V. Makarov, James B. Yu	1
18	Prostate Cancer Imaging Trends After a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging 2013 ·JNCI Journal of the National Cancer Institute ·Danil V. Makarov, Stacy Loeb, David Ulmert, (unknown), Mats Lambe, P Stattin	42
19	The Association Between Diffusion of the Surgical Robot and Radical Prostatectomy Rates 2011 ·Medical Care ·Danil V. Makarov, James B. Yu, Rani A. Desai, David F. Penson, Cary P. Gross	61
20	Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer 2009 ·Clinical Cancer Research ·Danil V. Makarov, Sumit Isharwal, Lori J. Sokoll, Patricia Landis, Cameron Marlow, Jonathan I. Epstein, Alan W. Partin, (unknown), Robert W. Veltri	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact